Technical Detail | 22 G |
Materials | HDPE |
CAD Model Available | No |
Manufacturing Aids - Mold Release - Lubricant used | No |
Colorant in Part | Yes |
Regrind Percentage | 50 |
Regrind Used to Manufacture This Part | Yes |
Hazardous Goods | No |
Product Shelf Life Non-Irradiation (months) | No shelf life indicated by the supplier |
California Prop. 65 | NO Substances on the California Proposition 65 list have been knowingly or intentionally added |
California Prop. 65 List Date | 12/29/2023 12:00:00 am |
Conflict Minerals | Not known to contain tantalum, tin, tungsten or gold. |
EU MDR 10.4.1 (CMR/ED) | No Substance(s) Present Above Threshold |
EU MDR 10.4.1 (CMR/ED) Substance List | Annex VI to CLP_ATP20 - 01 February 2025 |
European Pharmacopoeia (EP) 3.1.X | Pass 3.1.5 Polyethylene |
Latex | Does NOT intentionally contain natural latex |
Latex in Packaging | Does NOT intentionally contain natural latex |
REACH SVHC | No Substance(s) Present Above Threshold |
REACH SVHC Candidate List | 2024 June 27 (241 Substances) |
RoHS3 (2015/863) | Conforms to requirements of RoHS 2015/863 (RoHS3) |
Biocompatibility tested ISO 10993 | No |
Residual Solvents: Tested via ICH Q3C Standard | No ICH Q3C Testing Performed |
Protein Absorption Data Available | No |
Extractables Testing Claims | No Extractables Testing Performed |
Bioburden USP 61 62 | No bioburden information available |
Tested via USP 661.1 | No |
Integrity Tested? | No |
The products in our inventory are intended solely for use as components for further manufacturing, processing or incorporation into a finished device. These products are not intended for use as finished devices. Customers are solely responsible for determining whether a Qosina component product is appropriate for customer’s intended use and for ensuring that the use of the component product is in compliance with applicable laws. Our components are not available for sale to hospitals, physicians, and pharmacists.